Role of different nitric oxide synthase isoforms in a murine model of acute lung injury and sepsis

Biochemical and Biophysical Research Communications

Volumn 399, Issue 2, 2010, Pages 286-291

  Lange, Matthias ^a,b   Nakano, Yoshimitsu ^a   Traber, Daniel L ^a   Hamahata, Atsumori ^a,c   Esechie, Aimalohi ^a   Jonkam, Collette ^a   Bansal, Kamna ^a   Traber, Lillian D ^a   Enkhbaatar, Perenlei ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Mice; Neuronal nitric oxide synthase; Nitrosative stress; Oxidative stress; Smoke inhalation

Indexed keywords

CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; REACTIVE NITROGEN SPECIES; VASCULOTROPIN;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; LIPID PEROXIDATION; MORTALITY; MOUSE; NEUTROPHIL COUNT; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; PSEUDOMONAS AERUGINOSA; SEPSIS; SURVIVAL RATE;

ACUTE LUNG INJURY; ANIMALS; DISEASE MODELS, ANIMAL; EDEMA; FEMALE; MICE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; PSEUDOMONAS AERUGINOSA; REACTIVE NITROGEN SPECIES; SEPSIS;

GOSSYPIUM HIRSUTUM; MURINAE; MUS; PSEUDOMONAS AERUGINOSA;

EID: 77955847058     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.07.071     Document Type: Article

References (28)

1. Rue L.W., Cioffi W.G., Mason A.D., McManus W.F., Pruitt B.A. The risk of pneumonia in thermally injured patients requiring ventilatory support. J. Burn Care Rehabil. 1995, 16:262-268.
2. Shirani K.Z., Pruitt B.A., Mason A.D. The influence of inhalation injury and pneumonia on burn mortality. Ann. Surg. 1987, 205:82-87.
3. Annane D., Aegerter P., Jars-Guincestre M.C., Guidet B. Current epidemiology of septic shock: the CUB-Rea Network. Am. J. Respir. Crit. Care Med. 2003, 168:165-172.
4. Landry D.W., Oliver J.A. The pathogenesis of vasodilatory shock. N. Engl. J. Med. 2001, 345:588-595.
5. Szabo C. The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock 1996, 6:79-88.
6. Szabo C., Ischiropoulos H., Radi R. Peroxynitrite: biochemistry pathophysiology and development of therapeutics. Nat. Rev. Drug Discov. 2007, 6:662-680.
7. Jagtap P., Szabo C. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat. Rev. Drug Discov. 2005, 4:421-440.
8. Virag L., Szabo C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol. Rev. 2002, 54:375-429.
9. Szabo C., Cuzzocrea S., Zingarelli B., O'Connor M., Salzman A.L. Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly(ADP-ribose) synthetase by peroxynitrite. J. Clin. Invest. 1997, 100:723-735.
10. Zhang J., Dawson V.L., Dawson T.M., Snyder S.H. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 1994, 263:687-689.
11. Enkhbaatar P., Murakami K., Shimoda K., Mizutani A., McGuire R., Schmalstieg F., Cox R., Hawkins H., Jodoin J., Lee S., Traber L., Herndon D., Traber D. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole attenuates acute lung injury in an ovine model. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 285:R366-R372.
12. Okamoto I., Abe M., Shibata K., Shimizu N., Sakata N., Katsuragi T., Tanaka K. Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture. Am. J. Respir. Crit. Care Med. 2000, 162:716-722.
13. Lopez A., Lorente J.A., Steingrub J., Bakker J., McLuckie A., Willatts S., Brockway M., Anzueto A., Holzapfel L., Breen D., Silverman M.S., Takala J., Donaldson J., Arneson C., Grove G., Grossman S., Grover R. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit. Care Med. 2004, 32:21-30.
14. Lange M., Hamahata A., Traber D.L., Esechie A., Jonkam C., Bansal K., Nakano Y., Traber L.D., Enkhbaatar P. A murine model of sepsis following smoke inhalation injury. Biochem. Biophys. Res. Commun. 2010, 391:1555-1560.
15. Tao W., Deyo D.J., Traber D.L., Johnston W.E., Sherwood E.R. Hemodynamic and cardiac contractile function during sepsis caused by cecal ligation and puncture in mice. Shock 2004, 21:31-37.
16. Fagon J.Y., Chastre J., Hance A.J., Montravers P., Novara A., Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am. J. Med. 1993, 94:281-288.
17. Leu H.S., Kaiser D.L., Mori M., Woolson R.F., Wenzel R.P. Hospital-acquired pneumonia. Attributable mortality and morbidity. Am. J. Epidemiol. 1989, 129:1258-1267.
18. Vincent J.L., Sakr Y., Sprung C.L., Ranieri V.M., Reinhart K., Gerlach H., Moreno R., Carlet J., Le Gall J.R., Payen D. Sepsis in European intensive care units: results of the SOAP study. Crit. Care Med. 2006, 34:344-353.
19. Bakker J., Grover R., McLuckie A., Holzapfel L., Andersson J., Lodato R., Watson D., Grossman S., Donaldson J., Takala J. Administration of the nitric oxide synthase inhibitor NG-methyl-l-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002). Crit. Care Med. 2004, 32:1-12.
20. Booke M., Hinder F., McGuire R., Traber L.D., Traber D.L. Selective inhibition of inducible nitric oxide synthase: effects on hemodynamics and regional blood flow in healthy and septic sheep. Crit. Care Med. 1999, 27:162-167.
21. Su C.F., Yang F.L., Chen H.I. Inhibition of inducible nitric oxide synthase attenuates acute endotoxin-induced lung injury in rats. Clin. Exp. Pharmacol. Physiol. 2007, 34:339-346.
22. Watson D., Grover R., Anzueto A., Lorente J., Smithies M., Bellomo R., Guntupalli K., Grossman S., Donaldson J., Le Gall J.R. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-l-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002). Crit. Care Med. 2004, 32:13-20.
23. Nathan C., Xie Q.W. Nitric oxide synthases: roles, tolls, and controls. Cell 1994, 78:915-918.
24. Thiemermann C. Nitric oxide and septic shock. Gen. Pharmacol. 1997, 29:159-166.
25. Titheradge M.A. Nitric oxide in septic shock. Biochim. Biophys. Acta 1999, 1411:437-455.
26. Gocan N.C., Scott J.A., Tyml K. Nitric oxide produced via neuronal NOS may impair vasodilatation in septic rat skeletal muscle. Am. J. Physiol. Heart Circ. Physiol. 2000, 278:H1480-1489.
27. Kapoor M., Howard R., Hall I., Appleton I. Effects of epicatechin gallate on wound healing and scar formation in a full thickness incisional wound healing model in rats. Am. J. Pathol. 2004, 165:299-307.
28. Platt D.H., Bartoli M., El-Remessy A.B., Al-Shabrawey M., Lemtalsi T., Fulton D., Caldwell R.B. Peroxynitrite increases VEGF expression in vascular endothelial cells via STAT3. Free Radic. Biol. Med. 2005, 39:1353-1361.